Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor- Unfractionated Heparin Complex Inhibits Early Graft Thrombosis


AKŞİT E. , KURT T. , Buyuk B., Cokkalender O.

BALKAN MEDICAL JOURNAL, cilt.37, ss.269-275, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background: Bypass graft surgery remains to be an important treatment option for left main and multivessel coronary artery disease. Approximately 2% of saphenous vein grafts are lost immediately after the coronary artery bypass graft operations and 12% in the first month due to thrombosis.